Related Experiment Videos
Resistant respiratory pathogens and extended-spectrum antibiotics
1Department of Microbiology and Immunology, University of Rochester Medical Center, NY 14642, USA.
American Family Physician
|November 1, 1995
Summary
Traditional antibiotics like amoxicillin are less effective against resistant bacteria. Newer extended-spectrum antibiotics offer an alternative for bacterial respiratory infections, improving treatment outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Traditional antibiotics (amoxicillin, tetracycline, erythromycin) are first-line for bacterial respiratory infections.
- Antibiotic effectiveness is limited by local resistance patterns and patient factors.
- Significant resistance exists in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to amoxicillin and penicillin.
Purpose of the Study:
- To evaluate the role of newer extended-spectrum oral antibiotics.
- To identify alternatives for bacterial respiratory infections caused by resistant pathogens.
Main Methods:
- Review of antibiotic resistance patterns in the United States.
- Analysis of the efficacy of extended-spectrum antibiotics against resistant strains.
Main Results:
- Amoxicillin and penicillin resistance rates are high for key respiratory pathogens.
- Extended-spectrum oral antibiotics demonstrate effectiveness against resistant organisms.
- Cefuroxime axetil, cefpodoxime, amoxicillin-clavulanate, clarithromycin, and azithromycin are effective alternatives.
Conclusions:
- Selective use of newer extended-spectrum antibiotics is indicated for resistant bacterial respiratory infections.
- These agents provide viable treatment options when traditional antibiotics fail.
- Understanding local resistance is crucial for effective antibiotic selection.